Pain + Depressive Symptoms Increase Risk for Cognitive Decline
By Lori Solomon HealthDay Reporter
MONDAY, Dec. 2, 2024 -- The coexistence of moderate-to-intense pain and depressive symptoms is a risk factor for the decline of global cognition and memory, according to a study recently published in Aging & Mental Health.
Patrícia Silva Tofani, Ph.D., from the Federal University of Sergipe in Brazil, and colleagues assessed whether the coexistence of pain and depressive symptoms is a risk factor for cognitive decline in individuals aged 50 years and older. The analysis included longitudinal data from 4,718 participants in the English Longitudinal Study of Ageing.
The researchers found that during 12 years of follow-up, individuals with moderate/intense pain and depression had a greater memory decline (−0.038 standard deviation per year) and global cognition score (−0.033 standard deviation per year) compared with those with no pain and no depression.
"It's relatively common for people to mistakenly attribute symptoms of depression and pain as normal factors of aging. And they're not," coauthor Tiago da Silva Alexandre, Ph.D., from the Federal University of São Carlos in Brazil, said in a statement. "This belief leads professionals who are not specialists in gerontology and geriatrics to minimize the complaints of older people in primary care and to fail to diagnose and treat modifiable conditions."
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Alopecia Areata Associated With Severe Psychosocial Impact
THURSDAY, July 24, 2025 -- Alopecia areata (AA) has a severe psychosocial impact, which is linked to illness perceptions and stigma more strongly than disease severity, according...
Cancer Anxiety Impacts Family Members of Those Diagnosed With Cancer
WEDNESDAY, July 23, 2025 -- A cancer diagnosis places an emotional burden on the loved ones of those diagnosed, according to the results of a survey released by the Ohio State...
GLP-1 Receptor Agonists Tied to Decrease in T2DM-Related Dementia Risk
WEDNESDAY, July 23, 2025 -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.